$3.22
-0.28 (-8.00%)
Vical, Inc. (NASDAQ:VICL)
CAPS Rating:
The Company researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.
RSS Headlines
Fool UK